ZTS · 2 developments mapped · last assessed 2026-09-13
Market Ontology has mapped 2 macro, policy, and market developments to Zoetis Inc. since 2026-09-09. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Last close
Unavailable
No published quote
Market cap
Unavailable
Equity value
Diluted shares
Unavailable
Latest reported
Sector
Unavailable
Listing
Unavailable
Filings
Unavailable
No published filing
Valuation
No validated run has been published for ZTS yet, so no modelled value is shown. The ZTS valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run ZTS on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
A validated filed-statement snapshot has not been published for ZTS. Missing data is not estimated or replaced with scenario assumptions.
Current case
Open question
Cooper Companies Cuts FY Guidance on U.S. Channel Destocking
Second-order effect: While not directly in optical medical devices, Zoetis operates in animal health, which also relies on distributor networks. Broad destocking trends could potentially extend to other healthcare-related distribution channels, though less directly.
· Moves near term sales growth, distributor inventory management
What changed, by assumption
Near term sales growth
2026-09-13Cooper Companies Cuts FY Guidance on U.S. Channel Destocking
Market growth rate for animal health
2026-09-09Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 Guidance